Blockchain in Pharmaceutical Companies, Market Growth and Innovation with Company Profile 2026

Companies and Offerings in the Blockchain in Pharmaceutical Market

See what the full report offers before you invest; our sample is customized to your business.
Get it for free now

Market Forecast 2026-2035

The global blockchain in pharmaceutical market size was estimated at USD 1.14 billion in 2025 and is predicted to increase from USD 1.43 billion in 2026 to approximately USD 11.23 billion by 2035, expanding at a CAGR of 25.7% from 2026 to 2035.

The Pharma & Biopharma Manufacturers Segment Was Dominant in the Market in 2025

Now it’s effortless to manage all your Pharmaceutical Market data in one powerful place - access the dashboard

Explanation

• Pharma & Biopharma Manufacturers account for 46% of the market, dominating due to their substantial demand for advanced solutions in drug production and biopharmaceutical manufacturing.
• CMOs/CDMOs represent 22% of the market and are the fastest growing segment, driven by increasing outsourcing of manufacturing and development services in the pharmaceutical industry.
• Healthcare Providers & Health Systems hold 14% of the market, supporting clinical care and health services but with a smaller share compared to manufacturers.
• Supply Chain Intermediaries account for 12% of the market, facilitating logistics and distribution, though their role is less dominant than the pharmaceutical manufacturers.
• Others make up 6% of the market, covering a variety of specialized end-users with a smaller share in the industry.

In 2025, the pharma & biopharma manufacturers segment registered dominance in the blockchain in pharmaceutical market by 46% in 2025. Dominance is led by the surging need to comply with strict regulations of the US Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD), rising demand to boost operational efficiency, lower spending, and adapt to advanced integrations. Mainly in tracking and tracing of drugs from raw materials to patients, blockchains bolster ensuring authenticity & preserving brand reputation.

Moreover, the CMOs/CDMOs segment is anticipated to expand at a rapid CAGR. Eventual developments are posing the wider adoption of Smart/Pharma 4.0 environments, where blockchain serves as a trust layer for automated, data-driven production for CMOs. Besides this, advanced technology is allowing for strategic alliances, which evolve into one-stop-shop circumstances for perfect data sharing around the comprehensive development-to commercialization chain.

What are the Key Developments in the Blockchain in Pharmaceutical Market?

• In January 2026, the Indian Pharmacopoeia Commission launched a novel QR code-based verification system to support consumers in checking the authenticity of drugs.
• In October 2025, Former ISRO scientist Abhishek Chakrala introduced PranaChain, a decentralized blockchain-powered healthcare platform to ensure secure, transparent, & consent-driven exchange of medical data.
• In September 2025, Hua Jian and Renhe rolled out the foremost global RWA platform for OTC drug transactions.